GYN Biopsy Growth Histologics markets Kylon biopsy devices in gynecologic procedures, offering tissue samples comparable to traditional metal tools while reducing instrument maintenance and sterilization costs. This presents a compelling upsell opportunity for gynecology clinics and pathology networks seeking cost-efficient, patient-friendly solutions.

Wound Care Expansion Kylon devices enable controlled debridement with reduced trauma and potential faster healing, creating cross-sell potential to wound care centers and hospital wound clinics looking to improve outcomes and patient throughput while differentiating from scalpel-based methods.

Global Deployment Recent global expansion press indicates momentum for international adoption. Target distributors and international hospital networks to accelerate market penetration, leveraging Histologics' single-use, disposable advantage to meet varying sterilization capabilities and regulatory needs.

Clinical Leadership With Dr. Neal Lonky as a recognized expert in female health, there is opportunity to build clinician-led pilot programs, case studies, and speaking engagements that can drive adoption among key opinion leaders and accelerate clinical validation in both GYN and wound care segments.

Strategic Partnerships The company’s tech stack and growth signals suggest potential partnerships with medical distributors, healthcare systems, and diagnostics labs. Propose collaborative pilots, bundled device kits, and integration with existing tissue sampling workflows to increase adoption and revenue per site.